Scientists spent decades searching for stronger drugs to fight elusive proteins. But what they discovered was far more elegant: our bodies already know how to destroy them—we just have to point them in the right direction.
Countless decisions are made every second inside the human body. Cells repair damaged tissues, fight invading microbes, and remove worn-out proteins, carrying out these tasks silently until something goes wrong.
Abnormal proteins can act as an “on” switch that drives cancer cells to keep growing. For decades, many of these harmful proteins have remained virtually untouchable because they lack the structural features that conventional drugs are designed to target.
This challenge gave rise to SORTAC (Sortase A-mediated Targeted Protein Removal), an emerging biotechnology that does not destroy harmful proteins through brute force. Instead, it teaches cells to recognize them as waste and eliminate them naturally. Rather than building an entirely new defense system, scientists are repurposing one that has been present inside every human cell all along.
Decoding the Cell's Recycling Blueprint
Every cell functions like a bustling metropolis. Thousands of proteins are produced every minute to carry out essential tasks. When these proteins become damaged or obsolete, they are broken down and recycled through sophisticated waste-disposal systems. Among the key players in this process are lysosomes—organelles that digest cellular debris and worn-out proteins into their basic building blocks, allowing them to be reused.
In many diseases, however, the delicate balance between protein production and degradation is disrupted. In Alzheimer’s disease, misfolded proteins accumulate until neurons lose their ability to function. In certain cancers, mutated proteins become permanently switched “on,” continuously signaling cells to divide uncontrollably. Many of these disease-causing proteins have long been considered “undruggable” because they lack the binding pockets that conventional drugs typically target.
Rather than trying to silence these proteins, researchers asked a different question: What if the body could simply remove them?
A New Set of Instructions
SORTAC works less like a weapon and more like an instruction manual.
Picture a group of sanitation workers in a city going about their regular collection route. They already know how to get rid of the trash; they just need the right bins out front.
The technology is based on Sortase A, an enzyme of bacterial origin that can attach molecular tags to selected proteins. These tags act as biological disposal markers, marking specific proteins for elimination by the cell’s existing waste management system.
Nothing has changed about the cleanup machinery. Lysosomes, enzymes, and recycling pathways keep doing what they have always done. The only difference is that scientists are giving new instructions about what should be collected.
Turning the "Undruggable" into the Removable
SORTAC provides those labels, enabling the body’s own systems to identify proteins that previously escaped removal. The key isn’t brute-forcing biology. It is talking to it.
For decades, pharmaceutical researchers have worked to shut down proteins implicated in disease. Many of these proteins, however, simply cannot be switched off because they lack the necessary binding sites.
Targeted protein degradation changes that philosophy. Rather than stopping a protein from functioning, it removes it altogether. SORTAC broadens this fast-developing field by providing a modular approach that directs proteins toward the body’s natural degradation pathways.
Because it works by assigning proteins for disposal instead of permanently altering cells or genes, researchers hypothesize that SORTAC could complement existing therapies and broaden the range of diseases that targeted protein removal can address.
In the study by Gustafsen et al. (2026), Reshaping the Progranulin/Sortilin Interaction for Targeted Degradation of Extracellular Proteins, the researchers demonstrated SORTAC’s ability to selectively remove proteins while keeping surrounding biological processes intact—a promising step toward more precise treatments for complex diseases.
Working with Nature
Many have described modern medicine as a battle against disease—a fight in which new drugs and more powerful technologies become the latest weapons.
SORTAC tells a different story. Its major innovation is not the creation of another molecular tool but the realization that evolution has already built a remarkably efficient waste-disposal system. Instead of replacing it, scientists are learning to redirect it.
This transition reflects a broader shift taking place in biotechnology. Increasingly, research is focused less on bending biology to our will and more on understanding how it already works.
By working with biology, rather than attempting to control it, therapies become less like conquerors and more like allies. Of course, SORTAC is still in its infancy and will require years of testing before it becomes a clinical therapy. But regardless of its success, it serves as a reminder that some of medicine’s greatest challenges may not require entirely new biological systems. Often, they simply require us to uncover what already exists.
Perhaps the future of medicine will not be about creating stronger weapons against disease. Perhaps it will be about learning the language of our own cells—rewriting their instructions one protein at a time and letting the body finish the job it has always known how to do.
Written by Jaimielyn T. Villapaña, Insight PH
Jaimielyn T. Villapaña, Insight PH is a dedicated campus journalist and contributor. Their insightful writing sparks meaningful conversations and keeps the community informed.
